Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Endophytes from Southeast Asia and Japan can produce useful substances like enzymes and antibiotics.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

High levels of androgens during early development may cause PCOS-like symptoms.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.